question, and i hope that you'll continue to look at that so that market forces can continue to preville, and then i don't think we would be faced with these shortages. >> gentleman yields back? that is round of questions for the subcommittee members. we have a couple members of the committee who joined us. chair recognizes mr. waldon for e couple questions. >> i thank the chair for having the hearing, and i appreciate the testimony from the two witnesses today. i got involved in this issue some time ago because of oncology that was brought to my attention and staff's attention, and the drug i recall he mentioned, and i'll try to say it right, doxirubison, an ovarian cancer drug, that he's prescribed for a long time, an effective drug i'm told. what was the fda's role in interrupting the production of that drug? can you speak to that? >> i can speak to it very generally. there were several companies that produced the drug. one of them was a major supplier also was the same producer for the drug dr. qoh mentioned earlier. some of the issues were the same, facility issues, production delay

question, and i hope that you'll continue to look at that so that market forces can continue to previlleand then i don't think we would be faced with these shortages. >> gentleman yields back? that is round of questions for the subcommittee members. we have a couple members of the committee who joined us. chair recognizes mr. waldon for e couple questions. >> i thank the chair for having the hearing, and i appreciate the testimony from the two witnesses today. i got involved in this issue some time ago because of oncology that was brought to my attention and staff's attention, and the drug i recall he mentioned, and i'll try to say it right, doxirubison, an ovarian cancer drug, that he's prescribed for a long time, an effective drug i'm told. what was the fda's role in interrupting the production of that drug? can you speak to that? >> i can speak to it very generally. there were several companies that produced the drug. one of them was a major supplier also was the same producer for the drug dr. qoh mentioned earlier. some of the issues were the same, facility issues, production delays